Blueprint Medicines Corp (BPMC)
90.72
-2.36
(-2.54%)
USD |
NASDAQ |
Mar 26, 16:00
90.70
-0.02
(-0.02%)
After-Hours: 20:00
Blueprint Medicines Max Drawdown (5Y): 69.50% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Biomarin Pharmaceutical Inc | 53.26% |
| Alnylam Pharmaceuticals Inc | 42.46% |
| Palatin Technologies Inc | 97.60% |
| Agios Pharmaceuticals Inc | 82.86% |
| Viking Therapeutics Inc | 89.26% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 1.496 |
| Beta (5Y) | 0.5753 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 50.62% |
| Historical Sharpe Ratio (5Y) | 0.1921 |
| Historical Sortino (5Y) | 0.3514 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.21% |